MONTAG A & ASSOCIATES INC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
MONTAG A & ASSOCIATES INC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$423,698
-10.6%
15,7450.0%0.03%
-6.9%
Q2 2023$474,082
-6.9%
15,7450.0%0.03%
-12.1%
Q1 2023$509,351
+12.9%
15,7450.0%0.03%
+10.0%
Q4 2022$451,252
+18.8%
15,7450.0%0.03%
+15.4%
Q3 2022$380,000
-30.0%
15,745
-20.7%
0.03%
-25.7%
Q2 2022$543,000
-32.2%
19,845
-5.0%
0.04%
-18.6%
Q1 2022$801,000
+19.7%
20,8900.0%0.04%
+30.3%
Q4 2021$669,000
+3.9%
20,890
-4.4%
0.03%
-5.7%
Q3 2021$644,000
-26.5%
21,845
-15.3%
0.04%
-25.5%
Q2 2021$876,000
+0.8%
25,790
-3.6%
0.05%
-4.1%
Q1 2021$869,000
-9.8%
26,7450.0%0.05%
-16.9%
Q4 2020$963,000
+0.4%
26,745
+9.2%
0.06%
-23.4%
Q3 2020$959,000
+6.8%
24,4850.0%0.08%
-2.5%
Q2 2020$898,000
+59.2%
24,4850.0%0.08%
+41.1%
Q1 2020$564,000
-21.3%
24,4850.0%0.06%
-1.8%
Q4 2019$717,000
+9.6%
24,4850.0%0.06%0.0%
Q3 2019$654,000
+4.5%
24,4850.0%0.06%
+1.8%
Q2 2019$626,00024,4850.06%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders